Kelly Schick
Human Resources Officer bij C4 THERAPEUTICS, INC.
Vermogen: 326 046 $ op 30-04-2024
Actieve functies van Kelly Schick
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
C4 THERAPEUTICS, INC. | Human Resources Officer | 12-01-2021 | - |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Corporate Officer/Principal | - | - |
Loopbaan van Kelly Schick
Eerdere bekende functies van Kelly Schick
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2011 | - |
AMAG PHARMACEUTICALS, INC. | Human Resources Officer | 01-09-2016 | - |
Opleiding van Kelly Schick
Boston University | Undergraduate Degree |
The Curtis L. Carlson School of Management | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Israël | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Human Resources Officer | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Technology Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Kelly Schick
- Ervaring